Search clinical trials for: Glucobay

Total 49 results

Medical University of Graz

Completed

Investigation of Correlation Between Concentrations of Glucose in Blood and Interstitial Fluid in Type 1 Diabetics

Type 1 Diabetes

Austria
Medical University of Graz

Completed

Efficacy, Usability Study of the GlucoTab System for Glycaemic Management in Type 2 Diabetic Patients at General Wards

Type 2 Diabetes

Austria
Medical University of Graz

Completed

Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management

Type 2 Diabetes

Austria
Bayer

Completed

A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

Diabetes Mellitus, Type 2

Germany
Bayer

Completed

A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg

Diabetes Mellitus, Type 2

Germany
Indiana University

Completed

Mobile Communication Technology for Adolescents With Diabetes

Type 1 Diabetes

United States
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Food Intake and the Adolescent Brain (ADOB)

Adolescent | Feeding Behavior | Brain

United States
University of Pennsylvania

Recruiting

Phenotyping Genetic Risk for Type 2 Diabetes

Diabetes Mellitus, Type 2 | Genetics

United States
Iowa State University
USA Dry Pea & Lentil Council

Completed

Metabolic Effects of Pulse Consumption on Biomarkers in Adults With Type 2 Diabetes or Met Syn (PGRIV)

Metabolic Syndrome | Type2 Diabetes Mellitus

United States
Baylor College of Medicine

Recruiting

Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial

Gestational Diabetes Mellitus

United States
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients

Glucose Intolerance | Cardiovascular Risk Factor | Postprandial Hyperglycemia

Mexico
Aichi Gakuin University

Unknown

Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)

Coronary Artery Disease | Diabetes Mellitus | Impaired Glucose Tolerance

Japan
Bayer

Completed

GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Diabetes Mellitus

Russian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
University Hospital Inselspital, Berne

Completed

Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2

Type 2 Diabetes Mellitus

Switzerland
University of Oxford
Bayer

Completed

Acarbose Cardiovascular Evaluation Trial (ACE)

Coronary Heart Disease | Acute Coronary Syndrome | Impaired Glucose Tolerance | Type 2 Diabetes Mellitus (T2DM)

China, Hong Kong
Bayer

Completed

Prevention of Postprandial Hyperglycemia by Acarbose May be a Promising Therapeutic Strategy for Reducing the Increased Risk for Cardiovascular Disease (ABDOMEN)

Diabetes Mellitus

Poland
Bayer

Completed

GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin

Diabetes Mellitus

Korea, Republic of
Bayer

Completed

Influence of Different Approaches to Dietary Advising on the Effects of Acarbose Treatment in Obese Diabetic Patients Under Real-life Setting (CATERING)

Diabetes Mellitus

Poland
Bayer

Completed

Special Drug Use Investigation of Glucobay OD

Diabetes Mellitus

Japan
Bayer

Completed

Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care

Diabetes Mellitus

Spain
Bayer

Completed

Diabetes Treatment With Glucobay in Combination With Metformin

Type 2 Diabetes Mellitus

India
Shanghai Jiao Tong University School of Medicine

Unknown

Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes

Type 2 Diabetes

China
Taipei Veterans General Hospital, Taiwan

Unknown

Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

Diabetes

Taiwan
Bayer

Completed

Diabetes Treatment With Glucobay in Combination With Sulfonylurea

Type 2 Diabetes Mellitus

India
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers

Healthy
Bayer

Withdrawn

Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy (STARCH AM)

Diabetes Mellitus
Bayer

Withdrawn

GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice (GLORY)

Diabetes Mellitus, Type 2
Bayer

Completed

Glucose Reduction by Early Acarbose Treatment in Basal Insulin (GREAN)

Diabetes Mellitus, Type 2

Korea, Republic of
Takeda

Completed

Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Bayer

Completed

GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients (GLOBE)

Type 2 Diabetes

India
Bayer

Completed

Bioequivalence Study for Acarbose / Metformin FDC

Diabetes Mellitus, Type II

Korea, Republic of
Novo Nordisk A/S

Completed

Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

China
Novartis Pharmaceuticals

Completed

Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors (ENERGY)

Diabetes Mellitus, Type 2

China
Bayer

Completed

Bioequivalence Study for Acarbose/Metformin FDC

Diabetes Mellitus, Type 2

China
Profil Institut für Stoffwechselforschung GmbH
Pendragon Medical AG Switzerland

Completed

Glucose Clamp Study to Prove Hypo- and Hyperglycemic Episodes Using a Non-invasive Glucose Monitoring Device

Diabetes Mellitus

Germany
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Completed

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines (AlfaEx)

Glucose Metabolism Disorders

Denmark
University Hospital, Antwerp

Completed

Glucose Control in the ICU Using Continuous Glucose Monitoring (REGIMEN)

Critical Illness

Belgium
Kenneth Madden

Completed

Acarbose and Older Adults With Postprandial Hypotension (PPH)

Syncope | Other Specified Hypotension

Canada
Peking University

Unknown

Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients (VISA-T2DM)

Obesity | Diabetes Mellitus, Type 2

China
Shanghai 6th People's Hospital

Unknown

the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix Insulin (CGMS)

Type 2 Diabetes

China
Zealand University Hospital

Completed

Treatment of Hypoglycemia Following Gastric Bypass Surgery

Obesity | Hypoglycemia | Surgery
AstraZeneca

Completed

24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy (SMART)

Type 2 Diabetes Mellitus

China
Zilin Sun

Completed

Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes

Type 2 Diabetes

China
Fifth Affiliated Hospital, Sun Yat-Sen University

Unknown

Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus
University of Florida

Completed

Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study

Prediabetic State

United States
Sanofi

Completed

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy (SWITCH)

Type 2 Diabetes Mellitus

China
Kuopio University Hospital

Completed

Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women (Osteo)

Osteoporosis
Sanofi

Completed

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive (ACADEMIC)

Type 2 Diabetes Mellitus

China
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)

Type 2 Diabetes Mellitus

3

Subscribe